EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H22O3 |
| Net Charge | 0 |
| Average Mass | 250.338 |
| Monoisotopic Mass | 250.15689 |
| SMILES | Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 |
| InChI | InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17) |
| InChIKey | HEMJJKBWTPKOJG-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Application: | antilipemic drug A substance used to treat hyperlipidemia (an excess of lipids in the blood). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gemfibrozil (CHEBI:5296) has functional parent valeric acid (CHEBI:17418) |
| gemfibrozil (CHEBI:5296) has role antilipemic drug (CHEBI:35679) |
| gemfibrozil (CHEBI:5296) is a aromatic ether (CHEBI:35618) |
| IUPAC Name |
|---|
| 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid |
| INNs | Source |
|---|---|
| gemfibrozil | ChemIDplus |
| Gemfibrozilo | ChemIDplus |
| gemfibrozilum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansäure | ChemIDplus |
| 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansäure | ChemIDplus |
| 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid | ChemIDplus |
| Gemfibrozil | KEGG DRUG |
| Brand Name | Source |
|---|---|
| Lopid | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Beilstein:1881200 | Beilstein |
| CAS:25812-30-0 | KEGG DRUG |
| CAS:25812-30-0 | ChemIDplus |